| Filed On | Filing |
|---|---|
| 01 Oct 2026 |
Form 4: Reinke Kristin Marie K, Director
Granted 48,368 Stock Options (right to buy) |
| 13 Jul 2026 |
Form 4: Perceptive Advisors Llc, Director and 3 others
Received 20,706 shares as a grant or award |
| 24 Jun 2026 |
Form 4: Hrtg GPE, Llc, 10% owner and 4 others
Bought 3,125,000 shares ($50M) |
| 24 Jun 2026 |
Form 4: Berns Paul L, Director
Bought 1,250,000 shares ($20M) |
| 24 Jun 2026 |
Form 4: Arch Venture Partners XIII, Llc, Director and 6 others
Bought 1,250,000 shares ($20M) |
| 22 Jun 2026 |
Form 4: Hrtg GPE, Llc, 10% owner and 4 others
Received 13,792,034 shares by conversion |
| 22 Jun 2026 |
Form 4: Arch Venture Partners XIII, Llc, Director and 6 others
Received 13,792,035 shares by conversion |
| 22 Jun 2026 |
Form 4: Pasternak Andy, Chief Strategy Officer
Received 79,640 shares as a grant or award |
| 22 Jun 2026 |
Form 4: Meeker David P, Director
Received 20,706 shares as a grant or award |
| 22 Jun 2026 |
Form 4: Berns Paul L, Director
Received 13,792,035 shares by conversion · Received 20,706 shares as a grant or award |
| 22 Jun 2026 |
Form 4: Moriarty John B, Chief Legal Officer
Received 47,784 shares as a grant or award |
| 22 Jun 2026 |
Form 4: Jahn Brianne, Chief Financial Officer
Received 79,640 shares as a grant or award |
| 22 Jun 2026 |
Form 4: Popovits Kimberly J, Director
Received 20,706 shares as a grant or award |
| 22 Jun 2026 |
Form 4: Walbert Timothy P, Director
Received 20,706 shares as a grant or award · Granted 57,573 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Gianakakos Anastasios, Director
Received 568,395 shares by conversion |
| 22 Jun 2026 |
Form 4: Giordano Douglas E., Director
Received 20,706 shares as a grant or award |
| 22 Jun 2026 |
Form 4: Edelberg Jay, Chief Medical Officer
Received 97,587 shares by conversion · Received 47,784 shares as a grant or award |
Loading...